Recent Posts
New developments in Advanced Pancreatic Cancer from ASCO GI 2013 – Part 2
The following is a guest post from Sally Church (known to many in the...
New Developments in Advanced Pancreatic Cancer from ASCO GI 2013 – Part 1
The following is a guest post from Sally Church (known to many in the...
#FoodChem Carnival: A bit o’ science on your Thanksgiving tippling
In my family, the first thing that happens when you walk in the door to my...
#ChemCoach Carnival: From Big Pharma to Non-Profit
We’re almost at the end of National Chemistry week, folks, and the...
Cantley Talks Pfizer CTI Collaboration
As drug companies forge closer ties with academic researchers, the value of...
After Nutley Closure, Roche Picks NYC For East Coast R&D Site
Just months after announcing it would close its storied Nutley, N.J.,...
Heptares solves first X-ray structure of Family B GPCR, but full details not yet public
In what might be the year’s biggest molecular teaser, Heptares...
Sanofi’s MS Pill Aubagio Wins FDA Approval
Another pill for multiple sclerosis has gotten FDA’s stamp of approval....
Trouble Brewing for New HCV Meds
In a blow to the Hepatitic C drug development arena, Bristol-Myers Squibb...
What Pfizer’s Bapineuzumab Failure Means for Parkinson’s Disease Research
The spectacular—and largely anticipated—failure of the Alzheimer’s...
Recent Comments